Amedisys Debt to Equity Ratio 2010-2024 | AMED

Current and historical debt to equity ratio values for Amedisys (AMED) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Amedisys debt/equity for the three months ending March 31, 2024 was 0.31.
Amedisys Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $0.95B $1.14B 0.83
2023-12-31 $0.94B $1.12B 0.84
2023-09-30 $0.93B $1.09B 0.85
2023-06-30 $0.92B $1.06B 0.87
2023-03-31 $0.81B $1.13B 0.72
2022-12-31 $0.87B $1.11B 0.79
2022-09-30 $0.91B $1.07B 0.85
2022-06-30 $0.96B $1.04B 0.93
2022-03-31 $0.89B $1.02B 0.87
2021-12-31 $0.88B $0.98B 0.90
2021-09-30 $0.99B $0.95B 1.04
2021-06-30 $0.72B $0.88B 0.83
2021-03-31 $0.78B $0.79B 0.99
2020-12-31 $0.76B $0.81B 0.93
2020-09-30 $0.85B $0.76B 1.12
2020-06-30 $0.92B $0.72B 1.28
2020-03-31 $0.76B $0.68B 1.12
2019-12-31 $0.62B $0.64B 0.97
2019-09-30 $0.61B $0.60B 1.01
2019-06-30 $0.64B $0.56B 1.14
2019-03-31 $0.66B $0.52B 1.27
2018-12-31 $0.23B $0.48B 0.49
2018-09-30 $0.28B $0.45B 0.63
2018-06-30 $0.34B $0.41B 0.84
2018-03-31 $0.29B $0.55B 0.53
2017-12-31 $0.30B $0.52B 0.58
2017-09-30 $0.29B $0.51B 0.56
2017-06-30 $0.31B $0.49B 0.63
2017-03-31 $0.27B $0.48B 0.57
2016-12-31 $0.27B $0.46B 0.59
2016-09-30 $0.28B $0.45B 0.62
2016-06-30 $0.28B $0.43B 0.66
2016-03-31 $0.30B $0.41B 0.72
2015-12-31 $0.27B $0.41B 0.66
2015-09-30 $0.27B $0.39B 0.69
2015-06-30 $0.27B $0.38B 0.70
2015-03-31 $0.26B $0.37B 0.70
2014-12-31 $0.27B $0.40B 0.68
2014-09-30 $0.30B $0.38B 0.78
2014-06-30 $0.34B $0.37B 0.91
2014-03-31 $0.36B $0.36B 1.00
2013-12-31 $0.35B $0.37B 0.95
2013-09-30 $0.38B $0.38B 1.00
2013-06-30 $0.24B $0.47B 0.51
2013-03-31 $0.25B $0.46B 0.54
2012-12-31 $0.28B $0.45B 0.61
2012-09-30 $0.30B $0.57B 0.53
2012-06-30 $0.32B $0.54B 0.59
2012-03-31 $0.33B $0.53B 0.61
2011-12-31 $0.34B $0.52B 0.65
2011-09-30 $0.34B $0.51B 0.65
2011-06-30 $0.41B $0.93B 0.44
2011-03-31 $0.42B $0.90B 0.47
2010-12-31 $0.42B $0.88B 0.48
2010-09-30 $0.42B $0.85B 0.49
2010-06-30 $0.44B $0.83B 0.53
2010-03-31 $0.44B $0.78B 0.56
2009-12-31 $0.44B $0.74B 0.59
2009-09-30 $0.45B $0.69B 0.65
2009-06-30 $0.44B $0.64B 0.69
2009-03-31 $0.49B $0.60B 0.82
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.202B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.827B 10.78
Quest Diagnostics (DGX) United States $16.063B 16.60
DaVita (DVA) United States $11.923B 14.81
Encompass Health (EHC) United States $8.608B 22.03
Chemed (CHE) United States $8.132B 25.20
Elanco Animal Health (ELAN) United States $6.597B 17.11
Option Care Health (OPCH) United States $5.235B 19.82
RadNet (RDNT) United States $4.632B 96.45
Astrana Health (ASTH) United States $2.666B 36.05
Addus HomeCare (ADUS) United States $2.179B 28.20
LifeStance Health (LFST) United States $2.095B 0.00
U.S Physical Therapy (USPH) United States $1.424B 38.10
Pennant (PNTG) United States $0.789B 41.67
Aveanna Healthcare Holdings (AVAH) United States $0.677B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00